{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:21:47Z","timestamp":1787649707680,"version":"build-2736575974"},"reference-count":41,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dutch Organisation for Knowledge and Innovation in Health, Healthcare and Well-being","award":["09120012010062"],"award-info":[{"award-number":["09120012010062"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Missense mutations in nuclear receptor (NR) transcription factors cause a number of genetic disorders, including PPARG mutations that result in familial partial lipodystrophy type 3 (FPLD3). Experimental assessment is essential to establish a newly identified mutation as disease-causing, as accurately predicting the effect of a new mutation in silico remains challenging due to the multifunctional and modular nature of these proteins. However, deep structure\u2013function characterization often requires specialized and technically demanding approaches, which may not be readily available. Therefore, we established a simple and robust experimental framework based on 4 complementary reporter assays that independently assess (1) ability of the full-length receptor to activate transcription; (2) integrity of the ligand-binding domain; (3) heterodimerization potential; and (4) DNA-binding capacity. As a proof of concept, we analyzed 3 uncharacterized FPLD3-associated loss-of-function variants and 2 bladder cancer\u2013associated gain-of-function variants. Together, the 4 complementary assays showed unique functional phenotypes for all 5 mutants that were further supported by coregulator profiling. We therefore conclude that this framework provides a simple and robust first-line approach to identify functional alterations in peroxisome proliferator\u2013activated receptor \u03b3 mutants with mechanistic resolution. This framework is broadly applicable across NRs and offers a scalable path to systematic variant interpretation both in research and clinical contexts.<\/jats:p>","DOI":"10.1210\/endocr\/bqag024","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:29:07Z","timestamp":1772868547000},"source":"Crossref","is-referenced-by-count":0,"title":["A simple and robust reporter-based framework for deep functional characterization of PPAR\u03b3 mutants"],"prefix":"10.1210","volume":"167","author":[{"given":"Rosalie","family":"Baak","sequence":"first","affiliation":[{"name":"Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University , 3584 CG Utrecht ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Westland","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University , 3584 CG Utrecht ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"de Lange","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University , 3584 CG Utrecht ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7639-6310","authenticated-orcid":false,"given":"Rene","family":"Houtman","sequence":"additional","affiliation":[{"name":"Precision Medicine Lab , Antoni van Leeuwenhoek Building, 5349AE Oss ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9713-7286","authenticated-orcid":false,"given":"Eric","family":"Kalkhoven","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University , 3584 CG Utrecht ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"1","key":"2026082504515553500_bqag024-B1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41392-025-02270-3","article-title":"Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions.","volume":"10","author":"Jin","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2026082504515553500_bqag024-B2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1172\/JCI92949","article-title":"Maturing of the nuclear receptor family","volume":"127","author":"Lazar","year":"2017","journal-title":"J Clin Invest"},{"issue":"4","key":"2026082504515553500_bqag024-B3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI88892","article-title":"Genetic disorders of nuclear receptors","volume":"127","author":"Achermann","year":"2017","journal-title":"J Clin Invest"},{"issue":"9","key":"2026082504515553500_bqag024-B4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrm914","article-title":"Signalling through nuclear receptors","volume":"3","author":"Tata","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"41","key":"2026082504515553500_bqag024-B5","doi-asserted-by":"crossref","first-page":"37731","DOI":"10.1074\/jbc.R100034200","article-title":"PPAR\u03b3: a nuclear regulator of metabolism, differentiation, and cell growth","volume":"276","author":"Rosen","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"2026082504515553500_bqag024-B6","first-page":"715","article-title":"Gene-gene and gene-environment interactions in lipodystrophy: lessons learned from natural PPAR\u03b3 mutants","volume":"1864","author":"Broekema","year":"2019","journal-title":"Biochim Biophys Acta BBA\u2014Mol Cell Biol Lipids"},{"key":"2026082504515553500_bqag024-B7","doi-asserted-by":"crossref","first-page":"624112","DOI":"10.3389\/fendo.2021.624112","article-title":"PPARgamma in metabolism, immunity, and cancer: unified and diverse mechanisms of action","volume":"12","author":"Hernandez-Quiles","year":"2021","journal-title":"Front Endocrinol"},{"issue":"24","key":"2026082504515553500_bqag024-B8","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1158\/0008-5472.CAN-17-1701","article-title":"Genomic activation of PPARG reveals a candidate therapeutic axis in bladder cancer","volume":"77","author":"Goldstein","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"2026082504515553500_bqag024-B9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41467-018-08157-y","article-title":"Recurrent activating mutations of PPAR\u03b3 associated with luminal bladder tumors","volume":"10","author":"Rochel","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"2026082504515553500_bqag024-B10","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1038\/s41467-021-26421-6","article-title":"Pparg signaling controls bladder cancer subtype and immune exclusion","volume":"12","author":"Tate","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"2026082504515553500_bqag024-B11","doi-asserted-by":"crossref","first-page":"106525","DOI":"10.1016\/j.isci.2023.106525","article-title":"A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer","volume":"26","author":"Tortora","year":"2023","journal-title":"iScience"},{"issue":"1","key":"2026082504515553500_bqag024-B12","first-page":"7","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","volume":"76","author":"Adzhubei","year":"2013","journal-title":"Curr Protoc Hum Genet"},{"issue":"7883","key":"2026082504515553500_bqag024-B13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41586-021-04043-8","article-title":"Disease variant prediction with deep generative models of evolutionary data","volume":"599","author":"Frazer","year":"2021","journal-title":"Nature"},{"issue":"2","key":"2026082504515553500_bqag024-B14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nbt.3769","article-title":"Mutation effects predicted from sequence co-variation","volume":"35","author":"Hopf","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2026082504515553500_bqag024-B15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2026082504515553500_bqag024-B16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet"},{"issue":"11","key":"2026082504515553500_bqag024-B17","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/molbev\/msz179","article-title":"GEMME: a simple and fast global epistatic model predicting mutational effects","volume":"36","author":"Laine","year":"2019","journal-title":"Mol Biol Evol"},{"issue":"13","key":"2026082504515553500_bqag024-B18","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2026082504515553500_bqag024-B19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41588-018-0167-z","article-title":"Predicting the clinical impact of human mutation with deep neural networks","volume":"50","author":"Sundaram","year":"2018","journal-title":"Nat Genet"},{"issue":"10","key":"2026082504515553500_bqag024-B20","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.ajhg.2021.08.012","article-title":"Improved pathogenicity prediction for rare human missense variants","volume":"108","author":"Wu","year":"2021","journal-title":"Am J Hum Genet"},{"issue":"8016","key":"2026082504515553500_bqag024-B21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"6664","key":"2026082504515553500_bqag024-B22","doi-asserted-by":"crossref","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"issue":"1","key":"2026082504515553500_bqag024-B23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41592-021-01362-6","article-title":"Protein structure predictions to atomic accuracy with AlphaFold","volume":"19","author":"Jumper","year":"2022","journal-title":"Nat Methods"},{"issue":"1","key":"2026082504515553500_bqag024-B24","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1038\/s41467-022-34766-9","article-title":"PPAR\u03b3 lipodystrophy mutants reveal intermolecular interactions required for enhancer activation","volume":"13","author":"Madsen","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"2026082504515553500_bqag024-B25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2006.09.003","article-title":"Non-DNA binding, dominant-negative, human PPAR\u03b3 mutations cause lipodystrophic insulin resistance","volume":"4","author":"Agostini","year":"2006","journal-title":"Cell Metab"},{"issue":"1","key":"2026082504515553500_bqag024-B26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41467-017-00981-y","article-title":"The quaternary architecture of RAR\u03b2\u2013RXR\u03b1 heterodimer facilitates domain\u2013domain signal transmission","volume":"8","author":"Chandra","year":"2017","journal-title":"Nat Commun"},{"key":"2026082504515553500_bqag024-B27","volume-title":"Zenodo","author":"Baak"},{"issue":"7","key":"2026082504515553500_bqag024-B28","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/MCB.22.7.1961-1970.2002","article-title":"The PHD type zinc finger is an integral part of the CBP acetyltransferase domain","volume":"22","author":"Kalkhoven","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"5","key":"2026082504515553500_bqag024-B29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/me.2006-0485","article-title":"Impaired peroxisome proliferator-activated receptor \u03b3 function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy","volume":"21","author":"Jeninga","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"10","key":"2026082504515553500_bqag024-B30","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1074\/mcp.M900209-MCP200","article-title":"Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor \u03b3 cofactor","volume":"8","author":"Koppen","year":"2009","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"2026082504515553500_bqag024-B31","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/ng.3700","article-title":"Prospective functional classification of all possible missense variants in PPARG","volume":"48","author":"Majithia","year":"2016","journal-title":"Nat Genet"},{"issue":"8","key":"2026082504515553500_bqag024-B32","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/jc.2018-02787","article-title":"Efficacy of metreleptin treatment in familial partial lipodystrophy due to PPARG vs LMNA pathogenic variants","volume":"104","author":"Sekizkardes","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"40","key":"2026082504515553500_bqag024-B33","doi-asserted-by":"crossref","first-page":"25252","DOI":"10.1074\/jbc.272.40.25252","article-title":"DNA binding properties of peroxisome proliferator-activated receptor subtypes on Various natural peroxisome proliferator response elements","volume":"272","author":"Juge-Aubry","year":"1997","journal-title":"J Biol Chem"},{"issue":"12","key":"2026082504515553500_bqag024-B34","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/cancers12123580","article-title":"Differential effects of cancer-associated mutations enriched in Helix H3 of PPAR\u03b3","volume":"12","author":"Jang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2026082504515553500_bqag024-B35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cen.12837","article-title":"Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3","volume":"84","author":"Miehle","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026082504515553500_bqag024-B36","doi-asserted-by":"crossref","first-page":"1394102","DOI":"10.3389\/fendo.2024.1394102","article-title":"Familial partial lipodystrophy resulting from loss-of-function PPAR\u03b3 pathogenic variants: phenotypic, clinical, and genetic features","volume":"15","author":"Soares","year":"2024","journal-title":"Front Endocrinol"},{"key":"2026082504515553500_bqag024-B37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.molmet.2018.12.005","article-title":"Natural helix 9 mutants of PPAR\u03b3 differently affect its transcriptional activity","volume":"20","author":"Broekema","year":"2019","journal-title":"Mol Metab"},{"issue":"1","key":"2026082504515553500_bqag024-B38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajhg.2013.05.022","article-title":"Dissecting disease inheritance modes in a three-dimensional protein network challenges the \u201cGuilt-by-Association\u201d principle","volume":"93","author":"Guo","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2026082504515553500_bqag024-B39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/msb.2009.80","article-title":"Edgetic perturbation models of human inherited disorders","volume":"5","author":"Zhong","year":"2009","journal-title":"Mol Syst Biol"},{"issue":"1","key":"2026082504515553500_bqag024-B40","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1038\/s41467-022-31686-6","article-title":"Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure","volume":"13","author":"Gerasimavicius","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"2026082504515553500_bqag024-B41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/prot.340100306","article-title":"Proline in \u03b1-helix: stability and conformation studied by dynamics simulation","volume":"10","author":"Yun","year":"1991","journal-title":"Proteins Struct Funct Bioinforma"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqag024\/67269262\/bqag024.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/5\/bqag024\/67269262\/bqag024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/5\/bqag024\/67269262\/bqag024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:52:07Z","timestamp":1787647927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqag024\/8510260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,7]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqag024","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,3,6]]},"article-number":"bqag024"}}